Skip to content
Catalyst

methylphenidatePapers

Papers about methylphenidate

papers
1,014
42 years, by papers

Newest first

851 to 900 of 1,014

Every paper here, unless its row says otherwiseIndexed under methylphenidate in PubMed's chemical list; returned by a PubMed search for methylphenidate

  • Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2007PMID 17822338

  • A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

    International journal of radiation oncology, biology, physics2007PMID 17869448

  • Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.

    Journal of clinical psychopharmacology2007PMID 17873677

  • A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder.

    Child and adolescent psychiatry and mental health2007PMID 17897473Returned by a PubMed search for methylphenidate

  • Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.

    Journal of clinical pharmacology2007PMID 17962423

  • Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

    Journal of child and adolescent psychopharmacology2007PMID 17979578

  • Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

    Journal of child and adolescent psychopharmacology2007PMID 17979579

  • Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

    Journal of child and adolescent psychopharmacology2007PMID 17979581

  • Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2007PMID 17979587

  • Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study.

    Journal of the American Academy of Child and Adolescent Psychiatry2007PMID 18030085

  • Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses.

    Pharmacoepidemiology and drug safety2007PMID 18041106

  • Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder.

    Journal of the American Academy of Child and Adolescent Psychiatry2007PMID 18049294

  • Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.

    Clinical toxicology (Philadelphia, Pa.)2007PMID 18058301

  • Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.

    International journal of clinical pharmacology and therapeutics2007PMID 18184535

  • The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder.

    Neurocase2007PMID 18781432

  • Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

    Drug and alcohol dependence2006PMID 16102908Indexed under methylphenidate in PubMed's chemical list

  • A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.

    Biological psychiatry2006PMID 16373066

  • Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine.

    Synapse (New York, N.Y.)2006PMID 16385551

  • Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

    Archives of pediatrics & adolescent medicine2006PMID 16389216

  • Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

    The American journal of medicine2006PMID 16443425

  • A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.

    The Canadian journal of clinical pharmacology2006PMID 16456216

  • Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.

    The American journal of geriatric psychiatry2006PMID 16473984

  • A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

    Journal of attention disorders2006PMID 16481664

  • Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial.

    Journal of psychiatry & neuroscience2006PMID 16496035

  • The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.

    Nicotine & tobacco research2006PMID 16497598Indexed under methylphenidate in PubMed's chemical list

  • Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study.

    Clinical rehabilitation2006PMID 16502746

  • PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

    The American journal of psychiatry2006PMID 16513858

  • Bioequivalence of a methylphenidate hydrochloride extended-release preparation: comparison of an intact capsule and an opened capsule sprinkled on applesauce.

    International journal of clinical pharmacology and therapeutics2006PMID 16550736

  • The effect of methylphenidate on the sleep-wake cycle of brain-injured patients undergoing rehabilitation.

    Sleep medicine2006PMID 16564212

  • [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood].

    Archives de pediatrie2006PMID 16597499

  • Effects of long-term methylphenidate treatment: a pilot follow-up clinical and SPECT study.

    Progress in neuro-psychopharmacology & biological psychiatry2006PMID 16616981

  • Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

    Journal of clinical oncology2006PMID 16648508

  • Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.

    Journal of the American Academy of Child and Adolescent Psychiatry2006PMID 16670648

  • Methylphenidate fails to improve gait and muscle tone in patients with sporadic and hereditary spastic paraplegia.

    Movement disorders2006PMID 16705687

  • Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

    Psychopharmacology2006PMID 16758238

  • Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2006PMID 16768642

  • A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

    Health technology assessment (Winchester, England)2006PMID 16796929

  • Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.

    Journal of the American Academy of Child and Adolescent Psychiatry2006PMID 16832317

  • Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.

    American journal of medical genetics2006PMID 16917950

  • Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.

    Experimental neurology2006PMID 16925997

  • Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.

    Pediatrics2006PMID 16950962

  • Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.

    Journal of child and adolescent psychopharmacology2006PMID 16958567

  • An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

    Journal of child and adolescent psychopharmacology2006PMID 16958569

  • Naturalistic long-term use of methylphenidate in bipolar disorder.

    Journal of clinical psychopharmacology2006PMID 16974196

  • Methylphenidate modulates cerebral post-stroke reorganization.

    NeuroImage2006PMID 16978883

  • Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.

    Journal of the American Academy of Child and Adolescent Psychiatry2006PMID 17023867

  • Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

    Journal of the American Academy of Child and Adolescent Psychiatry2006PMID 17023870

  • Safety and tolerability of methylphenidate in preschool children with ADHD.

    Journal of the American Academy of Child and Adolescent Psychiatry2006PMID 17028508

  • Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.

    Addiction (Abingdon, England)2006PMID 17034441

  • Pharmacological management for agitation and aggression in people with acquired brain injury.

    The Cochrane database of systematic reviews2006PMID 17054165

The next 50 papers

← Previous 50